Market Research

The RWE Centre of Expertise, part of Ipsos’ global healthcare business, consolidates Ipsos’ extensive capabilities in capturing and analysing real-world data with our deep understanding of compliance and regulations to create robust real-world evidence, an area of increasing priority for healthcare companies.

Ipsos is pleased to announce the launch of its intuitive pack screening tool, FastPack, on Ipsos.Digital. Now available on the Ipsos.Digital platform in the US, UK, Australia, India, and South Africa, it offers results in as little as four hours.

People do not separate their online and offline experiences into separate boxes; they feel equally real to us, existing on the same continuum. Communities should not be an exception.

Generative AI could be an enabler to deliver faster, cheaper, and better research results, but the key is asking the right questions.

Ipsos.Digital, a self-service research platform that offers clients fast, simplified access to global research capabilities and insights, today announces that it is available in Japanese.

While the domain of Generative Artificial Intelligence (AI) has been growing in recent years, ChatGPT accelerated its adoption and broke through as the first “mass” Generative AI application. It is important to take notice and put this and other emerging tools in perspective as the implications of the technologies will be far reaching and very fast.

Ipsos is pleased to announce the acquisition of Xperiti, a start-up specializing in Business-to-Business (B2B) research, with operations across the US, Israel and the Philippines.

Understanding why real-world treatment in oncology can be sub-optimal – and what can be done about it.

To help brands grapple with the volume of consumer-generated data, a new breed of AI-enabled Consumer Intelligence (AICI) solutions have come on the scene.